| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Baumal Caroline is a Chief Medical Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 3,020 | $25.53 | $77,096.67 | -3.2% | +63.4% | - | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 1,853 | $29.96 | $55,512.54 | -3.3% | -39.2% | -33.4% | |
| Jan 6, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 2,816 | $33.81 | $95,214.59 | -4.8% | -42.4% | -30.4% | |
| Jan 4, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 2,751 | $60.05 | $165,206.90 | -7.7% | -6.2% | -44.9% |